CClinicalTrials.gg
CompletedNCT04872569Updated Jan 16, 2024Results posted

Pilot Testing A Pregnancy Decision Making Tool for Women With Spinal Cord Injury (SCI)

An interventional study of Decision-making tool in Spinal Cord Injuries and Pregnancy Related, sponsored by University of Michigan. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-16.

Sponsored by University of Michigan · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this project is to pilot test a decision-making tool that is tailored for women with SCI to support them in the decision-making process. Pilot testing focuses on feasibility and preliminary efficacy.

Read the detailed description

The purpose of this project is to pilot test a decision-making tool that is tailored for women with SCI to support them in the decision-making process. Pilot testing focuses on feasibility and preliminary efficacy.

02

Conditions studied

  • Spinal Cord Injuries
  • Pregnancy Related

Keywords

  • Decision tool
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 23 is close to the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Spinal cord injury (traumatic or non-traumatic)
  • Need for assistance with daily life activities and/or personal care; women with mild, moderate or severe severity will be eligible
  • actively planning or in the process of making a decision about whether or not to get pregnant in the near future

Exclusion criteria

Exclusion Criteria:

  • No plans for getting pregnant
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Decision-making tool

    Women will receive the decision making tool and use for a 3 month period.

    Behavioral: Decision-making tool

Interventions

  • BehavioralDecision-making tool

    Participants will be directed to use the decision tool for 3 months using it at their own pace. The tool covers topics relevant to women with disabilities in considering or planning a pregnancy and reflects core elements of decision making tools based on the Ottawa Framework for Decision Support.

06

What researchers measure

Primary outcomes

  1. Final Decisional Conflict Scale Score - Values Clarity Sub-scale

    The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Values Clarity sub-scale refers to how much a respondent is clear about the values that guide their decision-making. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater clarity of values.

    Time frame: 12 weeks

  2. Final Decisional Conflict Scale Score - Support Sub-scale

    The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Support for Decision Making sub-scale refers to how much support a respondent has from others about their decision-making. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater support for decision-making.

    Time frame: 12 weeks

  3. Final Decisional Conflict Scale Score - Uncertainty Sub-scale

    The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Uncertainty about the decision sub-scale refers to how much a respondent is uncertain about the decision. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater certainty about the decision.

    Time frame: 12 weeks

  4. Final Readiness to Make a Choice in Stage of Decision-Making Scale

    The Stage of Decision Making is a single item self-report measure. The options range from "haven't begun to think about choices" to "have already made a decision and unlikely to change my mind". The instructions were modified to refer to pregnancy and excluded the first two options of not having begun to think about choices given inclusion criteria. For this study, the scale ranged from 1 (are considering the decision now) to 4 (have already made a decision and am unlikely to change my mind). A higher score reflects greater readiness to make a decision.

    Time frame: 12 weeks

Secondary outcomes

  1. Feasibility - Acceptability

    Acceptability of decision making tool is refers to whether the intervention is agreeable or satisfactory. In this study we measured this by self-report. We used 13 items that measured the presentation of information of the tool rated on Likert scales ranging from 1 (poor) to 4 (excellent) which are summed across all items. Possible scores can range from 13 to 52, with higher scores reflecting better information presentation.

    Time frame: 12 weeks

  2. Feasibility - Demand

    Demand refers to the likelihood of using an intervention after the study is over. For this study, it is a single item rated on Likert scales of 1 (definitely not likely) to 5 (very likely). Higher scores indicate a higher likelihood of using the tool after the study is over.

    Time frame: 12 weeks

  3. Feasibility - Ease of Use

    Ease of use refers to how easy an intervention is to use. In this study, we measures ease of use of the tool with a self-report, single item rated on Likert scales ranging from 1 (very hard) to 5 (very easy). A higher rating means the tool was considered easier to use.

    Time frame: 12 weeks

07

Results

Posted Jan 16, 2024

Participant flow

Participant flow — Overall Study
MilestoneDecision-making Tool
Started23
Completed21
Not completed2
Withdrew: Withdrawal by subject2

Outcome measures

PrimaryFinal Decisional Conflict Scale Score - Values Clarity Sub-scale

The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Values Clarity sub-scale refers to how much a respondent is clear about the values that guide their decision-making. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater clarity of values.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Final Decisional Conflict Scale Score - Values Clarity Sub-scale
units on a scaleWomen Using Tool
Final Decisional Conflict Scale Score - Values Clarity Sub-scale13.4 ± 1.6
PrimaryFinal Decisional Conflict Scale Score - Support Sub-scale

The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Support for Decision Making sub-scale refers to how much support a respondent has from others about their decision-making. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater support for decision-making.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Final Decisional Conflict Scale Score - Support Sub-scale
units on a scaleDecision Making Tool
Final Decisional Conflict Scale Score - Support Sub-scale13.1 ± 2.0
PrimaryFinal Decisional Conflict Scale Score - Uncertainty Sub-scale

The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Uncertainty about the decision sub-scale refers to how much a respondent is uncertain about the decision. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater certainty about the decision.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Final Decisional Conflict Scale Score - Uncertainty Sub-scale
units on a scaleDecision Making Tool
Final Decisional Conflict Scale Score - Uncertainty Sub-scale11.8 ± 3.3
PrimaryFinal Readiness to Make a Choice in Stage of Decision-Making Scale

The Stage of Decision Making is a single item self-report measure. The options range from "haven't begun to think about choices" to "have already made a decision and unlikely to change my mind". The instructions were modified to refer to pregnancy and excluded the first two options of not having begun to think about choices given inclusion criteria. For this study, the scale ranged from 1 (are considering the decision now) to 4 (have already made a decision and am unlikely to change my mind). A higher score reflects greater readiness to make a decision.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Final Readiness to Make a Choice in Stage of Decision-Making Scale
units on a scaleDecision Making Tool
Final Readiness to Make a Choice in Stage of Decision-Making Scale3.19 ± 1.1
SecondaryFeasibility - Acceptability

Acceptability of decision making tool is refers to whether the intervention is agreeable or satisfactory. In this study we measured this by self-report. We used 13 items that measured the presentation of information of the tool rated on Likert scales ranging from 1 (poor) to 4 (excellent) which are summed across all items. Possible scores can range from 13 to 52, with higher scores reflecting better information presentation.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Feasibility - Acceptability
units on a scaleDecision Making Tool
Feasibility - Acceptability38.96 ± 6.5
SecondaryFeasibility - Demand

Demand refers to the likelihood of using an intervention after the study is over. For this study, it is a single item rated on Likert scales of 1 (definitely not likely) to 5 (very likely). Higher scores indicate a higher likelihood of using the tool after the study is over.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Feasibility - Demand
units on a scaleDecision Making Tool
Feasibility - Demand3.43 ± 1.1
SecondaryFeasibility - Ease of Use

Ease of use refers to how easy an intervention is to use. In this study, we measures ease of use of the tool with a self-report, single item rated on Likert scales ranging from 1 (very hard) to 5 (very easy). A higher rating means the tool was considered easier to use.

Time frame:
12 weeks
Reported as:
Mean · units on a scale
Feasibility - Ease of Use
units on a scaleDecision Making Tool
Feasibility - Ease of Use4.4 ± 1.0

Adverse events

Collected over 12 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Decision Making Tool0/23 (0%)0/23 (0%)0/23 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Decision-making Tool
<=18 years0
Between 18 and 65 years23
>=65 years0
Age, Continuous
Age, Continuous(years)Decision-making Tool
Mean32.7 ± 6.0
Sex: Female, Male
Sex: Female, Male(Participants)Decision-making Tool
Count by sex — Female23
Count by sex — Male0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Decision-making Tool
American Indian or Alaska Native0
Asian2
Native Hawaiian or Other Pacific Islander0
Black or African American1
White19
More than one race1
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Decision-making Tool
United States23
Decisional Conflict Scale, Values Clarity sub-scale
Decisional Conflict Scale, Values Clarity sub-scale(units on a scale)Decision-making Tool
Mean12.9 ± 1.7
Decisional Conflict Scale, Support for Decision Making sub-scale
Decisional Conflict Scale, Support for Decision Making sub-scale(units on a scale)Decision-making Tool
Mean12.1 ± 2.3
Decisional Conflict Scale, Uncertainty about the Decision sub-scale
Decisional Conflict Scale, Uncertainty about the Decision sub-scale(units on a scale)Decision-making Tool
Mean9.9 ± 3.7

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48170, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 29, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04872569
Lead sponsor
University of Michigan
Collaborators
The Craig H. Neilsen Foundation
Responsible party
Claire Z. Kalpakjian (Associate Chair, Department of Physical Medicine and Rehabilitation and Associate Professor of Physical Medicine and Rehabilitation, University of Michigan) — Principal investigator
First posted
May 4, 2021
Start date
Jul 28, 2021
Primary completion
May 11, 2022
Completion
May 11, 2022
Results posted
Jan 16, 2024
Last update
Jan 16, 2024

Study contacts

Claire Kalpakjian, PhD, MS
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion